{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-114919","form_type":"8-K","ticker":"DWTX","cik":"0001818844","company_name":"Dogwood Therapeutics, Inc.","filed_at":"2025-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.585857+00:00","generated_at":"2026-05-16T17:42:00.247460+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Dogwood Therapeutics completes business combination with Sealbond; approves equity plan adding 2.78M shares","bullets":["Stockholders approved the potential issuance of common stock upon conversion of Series A, A-1, and A-2 preferred stock.","Business combination with Sealbond Limited (per Share Exchange Agreement dated Oct 7, 2024) is now complete.","Second Amended and Restated Equity Incentive Plan approved, increasing reserved shares from 191,122 to 2,972,787.","Special meeting quorum: 820,239 shares (35.76% of voting power) as of Oct 14, 2025 record date.","All five proposals passed with >772K votes for, including adjournment and plan approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-114919","json":"https://secwatch.observer/filing/0001104659-25-114919.json","markdown":"https://secwatch.observer/filing/0001104659-25-114919.md","text":"https://secwatch.observer/filing/0001104659-25-114919.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818844/000110465925114919/0001104659-25-114919-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818844/000110465925114919/dwtx-20251121x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T17:42:00.247460+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}